Home / Pharmaceutical company intelligence
Nawan Laboratories Pvt Ltd logo
Pharmaceutical company intelligence

Nawan Laboratories products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer with branded generic, diagnostics and healthcare operations serving human and veterinary markets.

Nawan Laboratories products in Pakistan

Nawan Laboratories Pvt Ltd has 92 medicine presentations registered in Pakistan under 34 brands, covering 34 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Endocrine & metabolic. Its brands with the most registered strengths and packs are Metormin (Metformin), Ceftrix (Ceftriaxone), Epciwan (Levetiracetam) and Ivarlac (Rivaroxaban). 92 products have an official DRAP price on MedInfoBase. See all 34 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date17 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Nawan Laboratories (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
136-138, Sector 15, Korangi Industrial Area, Karachi, Pakistan
Phone
+92 21 35065835; +92 21 35059000
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000442 92 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx96public portfolio records represented
REG81unique registrations represented
IDX92indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+4registry-only registrations
VER39registry-verified exact registrations
PKR92current validated price records
G34generic molecules in indexed catalogue
DF6dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage96%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage100%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixNawan Laboratories Pvt LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nawan-laboratories-pvt-ltdGenerated 11 Nov 2026Anti-infectives44 · 48%CNS & mental health15 · 16%Endocrine & metabolic7 · 8%Hematology & thrombosis6 · 7%Cardiovascular5 · 5%Respiratory & allergy5 · 5%Vitamins, minerals & nutrition4 · 4%Other therapeutic areas6 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioNawan Laboratories Pvt LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nawan-laboratories-pvt-ltdGenerated 11 Nov 202692presentationsTablet60 · 65%Injection15 · 16%Capsule7 · 8%Suspension6 · 7%Syrup3 · 3%Sachet1 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionNawan Laboratories Pvt LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nawan-laboratories-pvt-ltdGenerated 11 Nov 202692comparable productsBelow peer median36 · 39%Near peer median33 · 36%Above peer median23 · 25%Company median price position+1.2%Lowest-price equivalents4Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsNawan Laboratories Pvt LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/nawan-laboratories-pvt-ltdGenerated 11 Nov 2026Nabiqasim Industries (Pvt) Ltd.,29 shared85% overlapBio-Labs(Pvt) Ltd28 shared82% overlapMediate Pharmaceutical Pvt Ltd27 shared79% overlapNeutro Pharma (Pvt.) Ltd.,25 shared74% overlapS.J & G. Fazul Ellahie (pvt) limite…25 shared74% overlapMacter International Limited24 shared71% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives44 products · 48%
CNS & mental health15 products · 16%
Endocrine & metabolic7 products · 8%
Hematology & thrombosis6 products · 7%
Cardiovascular5 products · 5%
Respiratory & allergy5 products · 5%
Vitamins, minerals & nutrition4 products · 4%
Gastrointestinal & hepatology3 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins15 products · 16%
Macrolide antibacterials9 products · 10%
SSRI antidepressants7 products · 8%
Antidiabetic medicines7 products · 8%
Antiepileptics6 products · 7%
Anticoagulants6 products · 7%
Fluoroquinolone antibacterials5 products · 5%
Antimalarials5 products · 5%
Formulation footprint

Dosage forms

Tablet60 products
Injection15 products
Capsule7 products
Suspension6 products
Syrup3 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 MetorminMetformin 7presentations 250 mg, 500 mg, 850 mg · Tablet #2 CeftrixCeftriaxone 6presentations 1 g, 250 mg, 500 mg · Injection #3 EpciwanLevetiracetam 6presentations 250 mg, 500 mg, 750 mg · Tablet #4 IvarlacRivaroxaban 6presentations 10 mg, 15 mg, 20 mg · Tablet #5 AziromycinAzithromycin 5presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #6 KelligaClarithromycin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Nawan Laboratories Pvt Ltd is priced against the market

92 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,361 products · 117 generics 29shared generics Bio-Labs(Pvt) Ltd234 products · 81 generics 28shared generics Mediate Pharmaceutical Pvt Ltd236 products · 89 generics 27shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers77Distinct registrations among indexed, published, presentation-validated products only
Verified price observations183
Products with a verified price92
Products with multiple price observations91
Source records with multiple versions92
Latest portfolio source check22 Sep 2026
Latest effective price date17 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

81 unique registration(s) · 92 indexed presentation(s) · 4 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Atrow Atorvastatin 10 mg Tablet 10's 090866 PKR 287.84 PKR 28.78/tablet 🔒 Pharma Pro
Atrow Atorvastatin 20 mg Tablet 10's 090867 PKR 487.12 PKR 48.71/tablet 🔒 Pharma Pro
Atrow Atorvastatin 40 mg Tablet 10's 090868 PKR 742.11 PKR 74.21/tablet 🔒 Pharma Pro
Aziromycin Azithromycin 200 mg/5 mL Suspension 15ml 024675 PKR 342.71 PKR 22.85/mL 🔒 Pharma Pro
Aziromycin Azithromycin 250 mg Capsule 6's 024676 PKR 319.04 PKR 53.17/capsule 🔒 Pharma Pro
Aziromycin Azithromycin 250 mg Capsule 10's 024676 PKR 564.94 PKR 56.49/capsule 🔒 Pharma Pro
Aziromycin Azithromycin 500 mg Tablet 6's 104300 PKR 575.81 PKR 95.97/tablet 🔒 Pharma Pro
Aziromycin Azithromycin 250 mg Tablet 6's 104301 PKR 314.08 PKR 52.35/tablet 🔒 Pharma Pro
Ceftrix Ceftriaxone 500 mg IV injection 1's Vial 039113 PKR 351.12 PKR 351.12/vial/unit 🔒 Pharma Pro
Ceftrix Ceftriaxone 250 mg IV injection 1's Vial 070804 PKR 196.20 PKR 196.20/vial/unit 🔒 Pharma Pro
Ceftrix Ceftriaxone 1 g IV injection 1's Vial 070805 PKR 619.59 PKR 619.59/vial/unit 🔒 Pharma Pro
Ceftrix Ceftriaxone 1 g IM injection 1's Vial 088935 PKR 602.74 PKR 602.74/vial/unit 🔒 Pharma Pro
Ceftrix Ceftriaxone 250 mg IM injection 1's Vial 088936 PKR 201.47 PKR 201.47/vial/unit 🔒 Pharma Pro
Ceftrix Ceftriaxone 500 mg IM injection 1's Vial 088937 PKR 339.10 PKR 339.10/vial/unit 🔒 Pharma Pro
Cipra Ciprofloxacin 500 mg Tablet 10's 082228 PKR 437.77 PKR 43.78/tablet 🔒 Pharma Pro
Cipra Ciprofloxacin 250 mg Tablet 10's 082229 PKR 264.70 PKR 26.47/tablet 🔒 Pharma Pro
CQP Chloroquine 250 mg Tablet 50 x 10's 104298 PKR 480.47 PKR 0.96/tablet 🔒 Pharma Pro
Difunol Fluconazole 50 mg Capsule 7's 092880 PKR 822.47 PKR 117.50/capsule 🔒 Pharma Pro
Difunol Fluconazole 150 mg Capsule 1's 092881 PKR 267.92 PKR 267.92/capsule 🔒 Pharma Pro
Efosul 1gm InjectionRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 082220Official source ↗ No indexed price — —
Efosul 2gm InjectionRegistry verified Cefoperazone as sodium, Sulbactum as sodium — — — 083927Official source ↗ No indexed price — —
Epciwan Levetiracetam 250 mg Tablet 30's 102775 PKR 1,323.41 PKR 44.11/tablet 🔒 Pharma Pro
Epciwan Levetiracetam 250 mg Tablet 10's 102775 PKR 479.79 PKR 47.98/tablet 🔒 Pharma Pro
Epciwan Levetiracetam 500 mg Tablet 30's 102776 PKR 2,194.47 PKR 73.15/tablet 🔒 Pharma Pro
Epciwan Levetiracetam 500 mg Tablet 10's 102776 PKR 796.59 PKR 79.66/tablet 🔒 Pharma Pro
Epciwan Levetiracetam 750 mg Tablet 30's 102777 PKR 2,925.96 PKR 97.53/tablet 🔒 Pharma Pro
Epciwan Levetiracetam 750 mg Tablet 10's 102777 PKR 1,062.12 PKR 106.21/tablet 🔒 Pharma Pro
Estex Escitalopram 5 mg Tablet 14's 083931 PKR 385.36 PKR 27.53/tablet 🔒 Pharma Pro
Estex Escitalopram 10 mg Tablet 14's 086045 PKR 770.70 PKR 55.05/tablet 🔒 Pharma Pro
Estex Escitalopram 20 mg Tablet 14's 086604 PKR 990.93 PKR 70.78/tablet 🔒 Pharma Pro
Fatoqin Hydroxychloroquine 200 mg Tablet 5 x 10's 104297 PKR 560.13 PKR 11.20/tablet 🔒 Pharma Pro
Fatoqin Hydroxychloroquine 200 mg Tablet 30's 104297 PKR 336.08 PKR 11.20/tablet 🔒 Pharma Pro
Fumarite Tenofovir disoproxil 300 mg Tablet 3 x 10's 128995 PKR 7,125.51 PKR 237.52/tablet 🔒 Pharma Pro
Fumarite Tenofovir disoproxil 300 mg Tablet 1's 128995 PKR 237.52 PKR 237.52/tablet 🔒 Pharma Pro
Halet Levofloxacin 250 mg Tablet 10's 079686 PKR 413.06 PKR 41.31/tablet 🔒 Pharma Pro
Halet Levofloxacin 500 mg Tablet 10's 079687 PKR 619.59 PKR 61.96/tablet 🔒 Pharma Pro
Irowan Iron polymaltose complex 100 mg elemental iron Tablet 10’s 079683 PKR 150.12 PKR 15.01/tablet 🔒 Pharma Pro
Irowan Iron polymaltose complex 50 mg/5 mL Syrup 120ml Bottle 079684 PKR 276.80 PKR 2.31/mL 🔒 Pharma Pro
Irowan Iron 50 mg/5 mL Syrup 60ml Bottle 079684 PKR 150.12 PKR 2.50/mL 🔒 Pharma Pro
Irowan-F Iron polymaltose complex + Folic acid 100 mg elemental iron + 0.35 mg folic acid Tablet 10's 079685 PKR 150.12 PKR 15.01/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 15 mg Tablet 10's 098859 PKR 6,086.08 PKR 608.61/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 10 mg Tablet 30's 098860 PKR 13,858.83 PKR 461.96/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 10 mg Tablet 10's 098860 PKR 4,619.61 PKR 461.96/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 20 mg Tablet 14's 098861 PKR 10,244.75 PKR 731.77/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 20 mg Tablet 7's 098861 PKR 5,391.35 PKR 770.19/tablet 🔒 Pharma Pro
Ivarlac Rivaroxaban 20 mg Tablet 10's 098861 PKR 7,701.92 PKR 770.19/tablet 🔒 Pharma Pro
Kelliga Clarithromycin 250 mg Tablet 10's 108494 PKR 389.90 PKR 38.99/tablet 🔒 Pharma Pro
Kelliga Clarithromycin 500 mg Tablet 10's 108495 PKR 649.83 PKR 64.98/tablet 🔒 Pharma Pro
Kelliga Clarithromycin 125 mg/5 mL Dry suspension 60ml Bottle 108496 PKR 362.28 PKR 6.04/mL 🔒 Pharma Pro
Kelliga Clarithromycin 250 mg/5 mL Dry suspension 60ml Bottle 108497 PKR 597.84 PKR 9.96/mL 🔒 Pharma Pro
A to Z

All 34 Nawan Laboratories brands in Pakistan

  • Atrow Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
  • Aziromycin Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
  • Ceftrix Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • Cipra Ciprofloxacin · 250 mg tablet, 500 mg tablet
  • CQP Chloroquine · 250 mg tablet
  • Difunol Fluconazole · 150 mg capsule, 50 mg capsule
  • Epciwan Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
  • Estex Escitalopram · 10 mg tablet, 20 mg tablet, 5 mg tablet
  • Fatoqin Hydroxychloroquine · 200 mg tablet
  • Fumarite Tenofovir disoproxil · 300 mg tablet
  • Halet Levofloxacin · 250 mg tablet, 500 mg tablet
  • Irowan Iron polymaltose complex, Iron · 100 mg elemental iron tablet, 50 mg/5 mL syrup
  • Irowan-F Iron polymaltose complex + Folic acid · 100 mg elemental iron + 0.35 mg folic acid tablet
  • Ivarlac Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
  • Kelliga Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Lorestin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • Maroxi Moxifloxacin · 400 mg tablet
  • Metormin Metformin · 250 mg tablet, 500 mg tablet, 850 mg tablet
  • Nawotax Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
  • Nenowan Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
  • Nowcef Cefixime · 100 mg/5 mL suspension, 400 mg capsule
  • Nowcef DS Cefixime · 200 mg/5 mL suspension
  • Oltrix Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
  • Oxluma Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
  • Oxzorid Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
  • Palsiwan Sertraline · 100 mg tablet, 50 mg tablet
  • Phinpen Meropenem · 1 g injection, 500 mg injection
  • Rigovir Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Rozvel Letrozole · 2.5 mg tablet
  • Salafem Fexofenadine · 120 mg tablet, 180 mg tablet, 60 mg tablet
  • Sartiwan Losartan · 100 mg tablet, 50 mg tablet
  • Sefvan Risperidone · 2 mg tablet, 4 mg tablet
  • Tonitol CR Paroxetine · 12.5 mg tablet, 25 mg tablet
  • Zaxro Ibuprofen · 600 mg sachet
Questions

Nawan Laboratories: common questions

How many products does Nawan Laboratories have in Pakistan?

Nawan Laboratories Pvt Ltd has 92 registered medicine presentations in Pakistan, sold under 34 brands and covering 34 generic medicines.

What are the main brands of Nawan Laboratories?

By number of registered strengths and packs, its largest brands are Metormin (Metformin), Ceftrix (Ceftriaxone), Epciwan (Levetiracetam), Ivarlac (Rivaroxaban) and Aziromycin (Azithromycin). This is not a sales ranking.

Which therapy areas does Nawan Laboratories cover?

The most products are in Anti-infectives (44), CNS & mental health (15), Endocrine & metabolic (7), Hematology & thrombosis (6) and Cardiovascular (5).

Where can I see Nawan Laboratories medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Nawan Laboratories Pvt Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/nawan-laboratories-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9